Listed

Omega Fund Management, LLC

An institutional investment manager in Boston, MA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1637359.

Share

Holdings: 10 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

Omega Fund Management, LLC, holdings
IssuerClassCUSIPReported value$mWeightSharesPut or callChange on the quarter before
Bicara Therapeutics Inc.BCAXCommon Stock05547710354.129.1%1,822,150Reduced−570,000
Nuvation Bio Inc.NUVBCommon Stock Class A67080N10145.924.7%8,081,089Unchanged
Kestra Med Technologies LtdCommon StockG5244110526.014.0%1,022,149Unchanged
BridgeBio Oncology Therapeutics Inc.BBOTCommon Stock10792410225.113.5%3,289,661Unchanged
Beta Bionics Inc.BBNXCommon Stock08659B10220.611.1%1,316,183Unchanged
Alumis Inc.ALMSCommon Stock0223071026.83.7%241,255Unchanged
Sana Biotechnology, Inc.SANACommon Stock7995661042.91.6%843,750Unchanged
ImageneBio, Inc.IMACommon Stock45175G2072.71.4%455,361Unchanged
enGene Holdings Inc.Common Stock29286M1051.50.8%876,357Unchanged
Odyssey Therapeutics Inc.ODTXCommon Stock67613T1040.1<0.1%2,893New+2,893

Sold out: 1 position

Held at the end of the quarter before and not reported this quarter.

Omega Fund Management, LLC, positions sold out
IssuerClassCUSIPReported value$WeightSharesPut or callChange on the quarter before
Replimune GroupREPLCommon Stock76029N1060.00.0%0Sold out−248,672

Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-350681 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.